Correspondence on Letter regarding "Personalized Approaches to the Treatment of Hepatocellular Carcinoma Using Immune Checkpoint Inhibitors"

Affiliations

• ¹ Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
• ² Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, CHA Bundang Medical Center, CHA University, Korea.
• ³ Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
• ⁴ Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.